Taylor Devices, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Taylor Devices, Inc. reports that CEO Timothy J. Sopko acquired 7,000 stock options on April 18, 2026.
NASDAQ
Taylor Devices, Inc. director Robert Michael Carey has acquired 7,000 stock options.
NASDAQ
Taylor Devices, Inc. reports that Chief Financial Officer Paul Murray Heary acquired 7,000 stock options.
NASDAQ
Director John Burgess of Taylor Devices, Inc. acquired 7,000 stock options on April 18, 2026, with an exercise price of $56.43.
NASDAQ
Fritz Eric Armenat, a Director at Taylor Devices, Inc., acquired stock options for 7,000 shares.
NASDAQ
Director John Burgess of Taylor Devices, Inc. reported transactions involving the acquisition and disposition of common stock.
NASDAQ
F. Eric Armenat, a director at Taylor Devices, Inc., sold all 4,328 of his directly held common stock shares across multiple transactions in January 2026.
NASDAQ
TAYLOR DEVICES, INC. Director Fritz Eric Armenat exercised stock options and subsequently sold a portion of the acquired shares to cover tax obligations.
NASDAQ
TAYLOR DEVICES, INC. Director Fritz Eric Armenat reported selling 4,120 shares of common stock under a Rule 10b5-1 plan, divesting all direct beneficial ownership.
NASDAQ
Taylor Devices Director Fritz Eric Armenat exercised stock options and subsequently sold a portion of the acquired shares.
NASDAQ
Timothy J. Sopko, CEO of Taylor Devices, Inc., recently acquired additional shares of the company's common stock.
NASDAQ
Timothy John Sopko, CEO of Taylor Devices, Inc., reports the acquisition of 7,000 stock options on April 18, 2025.
NASDAQ
Robert Michael Carey, a director at Taylor Devices, Inc., acquired 7,000 stock options on April 18, 2025.
NASDAQ
Paul Murray Heary, CFO of Taylor Devices, Inc., reports the acquisition of 7,000 stock options on April 18, 2025.
NASDAQ
John Burgess, a director at Taylor Devices, Inc., acquired 7,000 stock options on April 18, 2025, at an exercise price of $30.55.
NASDAQ
Fritz Eric Armenat, a director at Taylor Devices, Inc., acquired 7,000 stock options on April 18, 2025, at an exercise price of $30.55.
NASDAQ
Alan Raymond Klembczyk, President of Taylor Devices, Inc., reports the acquisition of 7,000 stock options on April 18, 2025.
NASDAQ
Director John Burgess exercised stock options and disposed of 5,000 shares of Taylor Devices, Inc. common stock on April 14, 2025.
NASDAQ
Taylor Devices CEO, Timothy John Sopko, purchased 1,000 shares of company stock at $33.25 per share on January 13, 2025.
NASDAQ
Director Robert Michael Carey exercised stock options and disposed of shares of Taylor Devices, Inc. on October 28, 2024.
NASDAQ
Alan Raymond Klembczyk, President of Taylor Devices, Inc., exercised stock options on September 18, 2024, acquiring 8,000 shares of common stock.
NASDAQ
Paul Murray Heary, CFO of Taylor Devices Inc., reports the acquisition of 7,000 stock options on April 18, 2024.
NASDAQ
Timothy John Sopko, CEO of Taylor Devices Inc., acquired 7,000 stock options on April 18, 2024.
NASDAQ
Robert Michael Carey, a director at Taylor Devices Inc., acquired 7,000 stock options on April 18, 2024.
NASDAQ
F. Eric Armenat, a director of Taylor Devices Inc., acquired 7,000 stock options on April 18, 2024.
NASDAQ
John Burgess, a director at Taylor Devices Inc., acquired 7,000 stock options on April 18, 2024, at an exercise price of $46.9926.
NASDAQ
Alan Raymond Klembczyk, President of Taylor Devices Inc., acquired 7,000 stock options on April 18, 2024.
NASDAQ
Director John Burgess exercised stock options and disposed of 5,000 shares of Taylor Devices Inc. common stock on April 8, 2024.